Early research (Phase 1)Study completedNCT01850238
What this trial is testing
Safety Study of AADvac1, a Tau Peptide-KLH-Conjugate Active Vaccine to Treat Alzheimer's Disease
Who this might be right for
Alzheimer Disease
Axon Neuroscience SE 30
Showing 20 of 51 results